In countries of the European Union, tuberculosis (TB) mainly affects marginalised people, including asylum seekers. Migratory flows from high-incidence countries to Italy have increased up to 2017, posing challenges to the national health system. This study sought to assess TB and latent TB infection (LTBI) prevalence among asylum seekers in Milan during the biennium 2016-2017 and to evaluate interventions in place.A two-level active surveillance and screening system was developed for both TB and LTBI. Asylum seekers underwent an initial screening with a tuberculin skin test (TST) and a questionnaire at the receiving sites. At the Regional TB Reference Centre, those with a positive result underwent chest radiography. People aged <35 years with negative chest radiography results underwent further testing by interferon-γ release assay. If results of the assay were positive, LTBI treatment was offered. TB and LTBI prevalence were compared with literature data.A total of 5324 asylum seekers, mostly young (10-39 years; 98%), male (84%) and from sub-Saharan Africa (69%), were enrolled in the study. 69 active TB cases were diagnosed and 863 LTBI-positive individuals were detected. TB prevalence was high (1236 per 100 000 population) and LTBI prevalence was 28%. Despite losses (41%) during the transition from initial screening sites and the diagnostic centre, a good TB cure rate (84%) and optimal LTBI treatment completion (94%) were achieved.Our study shows that TB incidence is high among asylum seekers in Milan and that well-coordinated screening measures are critical for early diagnosis and treatment. It also proves that rolling out successful at-scale interventions for both prophylaxis and disease management is feasible.

Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions / S. Villa, L.R. Codecasa, M. Faccini, M.M. Pontello, M. Ferrarese, P.F. Castellotti, S. Senatore, A. Lamberti, E. Mazzola, C.F. Perno, D. Campisi, M. Saporiti, M.C. Raviglione. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 1399-3003. - 54:4(2019 Oct 01). [10.1183/13993003.00896-2019]

Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions

S. Villa
Primo
;
M.M. Pontello;A. Lamberti;C.F. Perno;M.C. Raviglione
Ultimo
2019

Abstract

In countries of the European Union, tuberculosis (TB) mainly affects marginalised people, including asylum seekers. Migratory flows from high-incidence countries to Italy have increased up to 2017, posing challenges to the national health system. This study sought to assess TB and latent TB infection (LTBI) prevalence among asylum seekers in Milan during the biennium 2016-2017 and to evaluate interventions in place.A two-level active surveillance and screening system was developed for both TB and LTBI. Asylum seekers underwent an initial screening with a tuberculin skin test (TST) and a questionnaire at the receiving sites. At the Regional TB Reference Centre, those with a positive result underwent chest radiography. People aged <35 years with negative chest radiography results underwent further testing by interferon-γ release assay. If results of the assay were positive, LTBI treatment was offered. TB and LTBI prevalence were compared with literature data.A total of 5324 asylum seekers, mostly young (10-39 years; 98%), male (84%) and from sub-Saharan Africa (69%), were enrolled in the study. 69 active TB cases were diagnosed and 863 LTBI-positive individuals were detected. TB prevalence was high (1236 per 100 000 population) and LTBI prevalence was 28%. Despite losses (41%) during the transition from initial screening sites and the diagnostic centre, a good TB cure rate (84%) and optimal LTBI treatment completion (94%) were achieved.Our study shows that TB incidence is high among asylum seekers in Milan and that well-coordinated screening measures are critical for early diagnosis and treatment. It also proves that rolling out successful at-scale interventions for both prophylaxis and disease management is feasible.
Adolescent; Adult; Africa, Eastern; Africa, Northern; Africa, Western; Antitubercular Agents; Asia, Western; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Interferon-gamma Release Tests; Italy; Latent Tuberculosis; Male; Mass Screening; Prevalence; Radiography, Thoracic; Refugees; Treatment Outcome; Tuberculin Test; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult
Settore MED/17 - Malattie Infettive
Settore MED/42 - Igiene Generale e Applicata
1-ott-2019
14-ago-2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
1900896.full.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 419.75 kB
Formato Adobe PDF
419.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/816968
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact